26 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
with the director independence requirements and the audit committee and compensation committee composition requirements under U.S. laws (including applicable … directors under the respective “independence” requirements of the SEC and Nasdaq, each of whom is financially literate and one of whom has accounting
6-K
EX-99
BLRX
Bioline Rx Ltd
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
the independence requirements of an independent director as set forth by the Nasdaq Listing Rules and the Securities and Exchange Commission, including … the heightened independence standards to serve on the Company’s Audit Committee and Compensation Committee, and that upon his election
6-K
EX-99
uda4f87en18mk
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-1
lu71a28c255
28 May 19
Current report (foreign)
7:04am
20-F/A
nxxus3
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
ywiffxez x7n
24 Dec 14
Current report (foreign)
12:00am
424B3
lnnkucxmj343s
8 Aug 13
Prospectus supplement
12:00am
424B3
c8gbv 639wr183cqga
15 Oct 12
Prospectus supplement
12:00am